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Abstract
Matrix-assisted laser desorption ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS) is a powerful tool for the species and
subspecies classiﬁcation of a broad spectrum of bacteria, including Gram-positive bacteria such as Staphylococcus, Streptococcus and
Listeria, and Gram-negative bacteria such as Neisseria, Salmonella, Aeromonas, Campylobacter and Helicobacter. MALDI-TOF MS has also
been used for the rapid identiﬁcation and typing of potential bioterrorism agents, including Coxiella burnetii, Francisella tularensis and
Bacillus anthracis.
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Taxonomy is the systematic classiﬁcation of microbes on
the basis of their quantiﬁable properties. In the example of
bacterial classiﬁcation, macroscopic and microscopic proper-
ties were used initially to subdivide organisms into related
groups, followed by metabolic and antigenic properties, and
then, more recently, genomic relationships. Each approach
still has value for the clinical microbiologist. For example,
the Gram stain is a powerful tool for the initial classiﬁcation
of a bacterial isolate, biochemical tests can be used to iden-
tify most commonly isolated organisms, serological testing is
important for subtyping organisms such as b-haemolytic
Streptococcus and Salmonella, and sequencing of one or more
bacterial genes (or the entire genome) offers deﬁnitive clas-
siﬁcation of most bacteria, including organisms not previ-
ously recognized. Genomic techniques such as pulsed-ﬁeld
gel electrophoresis (PFGE), ampliﬁed fragment length poly-
morphism analysis and multilocus sequence typing are also
used to subtype bacteria for epidemiological studies.
Although any scheme used to classify organisms is based on
rules that deﬁne arbitrary divisions and a hierarchy of rela-
tionships (e.g. genus, species and subtype), genome analysis
is currently accepted as the prevailing standard. Thus, any
new technique, such as matrix-assisted laser desorption
ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS),
used to classify organisms must be compared with genomic
classiﬁcation. As discussed in the accompanying reviews,
microbial identiﬁcation with MALDI-TOF MS compares
favourably with biochemical and genomic identiﬁcation meth-
ods. Theoretically, because MALDI-TOF MS detects a large
spectrum of proteins, the technique should be able to dis-
criminate between closely related species and to classify
organisms at the subspecies level. A review of studies that
have evaluated MALDI-TOF MS for taxonomic and epidemi-
ological classiﬁcation of bacteria is presented here. It should
be noted that the current commercially available MALDI-
TOF MS systems are accurate and give reproducible results
for identiﬁcation of microbes at the species and subspecies
levels; however, a limited number of studies have been
reported that have used MALDI-TOF MS for microbial
typing and, in many cases, they have used markedly different
analytical procedures from those used for microbial identiﬁ-
cation. Thus, the studies summarized in this review should
be viewed as deﬁning the potential of MS for bacterial and
fungal strain typing, and additional work needs to be per-
formed to deﬁne the robustness of MALDI-TOF MS for this
application.
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A series of studies published by Edwards-Jones et al. [1–3]
demonstrated that MALDI-TOF MS could be used to identify
Staphylococcus aureus, discriminate between methicillin-resistant
S. aureus (MRSA) and methicillin-susceptible S. aureus strains,
and subtype MRSA strains. MRSA and methicillin-susceptible
S. aureus strains can be accurately differentiated by MALDI-
TOF MS signiﬁcantly faster than with conventional antimicro-
bial susceptibility test methods and less expensively than with
genomic techniques; thus, it will be important for other
investigators to conﬁrm these early studies, using the
currently available MALDI-TOF MS instruments and analytical
software. PFGE is a widely used, sensitive technique for sub-
typing MRSA strains [4], and has been used to deﬁne distinct
clusters of MRSA genotypes that have signiﬁcant value for
epidemiological studies [5]; however, PFGE is expensive and
technically demanding, and requires 2–3 days of processing.
MALDI-TOF MS, when performed under carefully standard-
ized conditions as described by Jackson et al. [3], can subtype
strains in a fraction of the time and with much less expense,
and allow real-time management of MRSA infections. It
should be noted that a systematic comparison of PFGE
and MALDI-TOF MS subtyping of MRSA stains has not
been reported, so it is unknown whether the classiﬁcation
of a population of strains by each method would yield
comparable results.
The genus Streptococcus is broadly subdivided into two
groups: the b-haemolytic streptococci, which are most com-
monly classiﬁed by Lanceﬁeld grouping and phenotypic tests;
and the viridans streptococci, a collection of more than 30
a-haemolytic and non-haemolytic species, organized into ﬁve
subgroups that are not readily identiﬁed by either phenotypic
tests or sequencing of the 16S rRNA gene [6]. Kumar et al.
[7] and Lartigue et al. [8] demonstrated that MALDI-TOF MS
could easily differentiate common Lanceﬁeld groups of strep-
tococci (groups A, B, C and G) and could be used to sub-
type group A and B streptococci. A more difﬁcult challenge
is to identify members of the viridans streptococci correctly;
however, Friedrichs et al. [9] correctly classiﬁed 99 clinical
isolates into ten individual species. In this study, Streptococcus
pneumoniae was excluded from the analysis, in part because
this species is readily identiﬁed by the bile solubility test, and
in part because it cannot be reliably differentiated from other
members of the Streptococcus mitis group by MALDI-TOF MS
[10]. Despite this limitation, subtyping of Streptococcus pneu-
moniae strains by MALDI-TOF MS can be reliably performed,
even for immunologically non-typeable or non-encapsulated
strains [11].
Listeria monocytogenes is an important foodborne pathogen
that is responsible for opportunistic infections in neonates,
pregnant women, elderly persons and immunocompromised
individuals. Foodborne outbreaks are associated with soft
cheeses and other dairy products, processed meats, and
lettuce and uncooked vegetables. Differentiation of L. mono-
cytogenes from other Listeria species and subtyping of
L. monocytogenes are important tools for epidemiological
investigations of food-related illnesses. Species identiﬁcation
is performed traditionally by phenotypic testing, and PFGE
is used to subtype isolates into three clonal lineages: lineage I
(serotypes 1/2b, 3b, 4b, 4ab, 4d, 4e and 7), lineage II
(serotypes 1/2a, 1/2c, 3a and 3c) and lineage III (sero-
types 4a and 4c). Barbuddhe et al. [12] demonstrated that
MALDI-TOF MS accurately identiﬁed 146 strains of Listeria
(representing six species) at the species level, and correctly
subtyped all strains of L. monocytogenes, with the results
corresponding to PFGE classiﬁcations.
Lactococcus is an uncommonly recognized bacterium, and
is frequently misidentiﬁed by phenotypic tests as Streptococ-
cus. The discriminatory power of MALDI-TOF MS was dem-
onstrated by Tanigawa et al. [13] when they accurately
identiﬁed six species and three subspecies of Lactococcus. In
contrast, although species classiﬁcation was obtained with
16S rRNA gene sequencing, subspecies identiﬁcation
required multilocus sequence analysis of three housekeeping
genes.
The genus Neisseria consists of two well-known human
pathogens, Neisseria gonorrhoeae and Neisseria meningitidis,
and 21 other species of non-pathogenic or opportunistic
pathogens. Although it is relatively easy to differentiate the
pathogenic species, misidentiﬁcation of the other species by
phenotypic or immunological tests as N. gonorrhoeae or
N. meningitidis can occur [14]. In contrast, Illina et al. [15]
demonstrated that MALDI-TOF MS readily separated 57
strains of Neisseria into three groups: N. gonorrhoeae, N. men-
ingitidis, and other species. Additionally, a dendogram of 15
strains of non-pathogenic species indicated that these would
also probably have been separated into individual species
proﬁles if additional strains had been evaluated.
The genus Salmonella was a taxonomic quagmire until
2005, when the more than 2500 serotypes (also called sero-
vars and previously referred to as species) were reorganized
into two species: Salmonella enterica and Salmonella bongori
[16]. Salmonella enterica was subdivided into six subspecies,
with most human pathogens being placed in Salmonella enterica
ssp. enterica (ssp. 1). Distinguishing among the Salmonella
serovars is important for clinical and epidemiological pur-
poses; however, the fact that most are classiﬁed in the same
species emphasizes the close genomic relationships among
these organisms. Serological testing, and not biochemical
tests, have historically been used to identify these organisms.
In 2003, Leuschner et al. [17] demonstrated that MALDI-TOF
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MS could be used to distinguish ﬁve serovars of Salmonella
enterica (22 isolates), and in 2008 Dieckmann et al. [18]
expanded these ﬁndings, demonstrating that 126 isolates of
Salmonella could be classiﬁed correctly at the species and
subspecies levels. Although relatively few biomarker peaks
(e.g. ﬁve to ten peaks) are needed to identify an isolate at
the species level, Dieckmann et al. [18] reported that a lar-
ger number of reproducible peaks were required for subspe-
cies identiﬁcation. This poses a challenge for clinical
laboratories that attempt to use MALDI-TOF MS for strain
typing. Whereas rigorous control of the sample preparation
is generally unnecessary for organism identiﬁcation, optimiza-
tion of testing parameters is most likely critical for strain
typing. For example, technical parameters such as the type
and concentration of the matrix, the sample preparation pro-
cedure, the matrix–solvent mixture, the concentration of
acid added to the matrix and the growth medium inﬂuenced
the mass spectral proﬁle of biomarkers. Dieckmann et al.
[18] evaluated three matrix mixtures, and found that sinapi-
nic acid produced the most informative spectra, particularly
in the higher molecular mass range. Through their optimiza-
tion procedures, the number of peaks (>300), particularly
high molecular mass peaks, was signiﬁcantly increased. Addi-
tionally, although commercial software was used to identify
biomarker peaks that could classify Salmonella at the genus,
species or subspecies level, the need for software speciﬁcally
designed for typing other microbial strains is unknown.
Aeromonas infections in humans most commonly present
as diarrhoeal disease in healthy individuals, soft tissue infec-
tion, frequently following exposure to contaminated fresh
water, or opportunistic systemic disease in immunocompro-
mised patients, particularly those with hepatobiliary disease
or an underlying malignancy. Differentiation of Aeromonas
species from Vibrio species and classiﬁcation of species and
subspecies within the genus Aeromonas cannot be performed
reliably with biochemical testing, particularly when commer-
cial identiﬁcation systems are used; likewise, classiﬁcation of
Aeromonas strains at the species and subspecies level cannot
be performed by sequencing the 16S rRNA gene. Sequencing
of other housekeeping genes, such as gyrB and rpoD, or mul-
tilocus sequence typing must be performed for accurate spe-
cies identiﬁcation. Thus, most laboratories are restricted to
identiﬁcation of isolates as members of the Aeromonas hydro-
phila complex, Aeromonas caviae complex or Aeromonas veronii
complex. In contrast to the limitations of phenotypic and
genomic tests, Donohue et al. [19] reported that MALDI-
TOF MS accurately classiﬁed 14 species and four subspecies
of Aeromonas, including A. hydrophila, A. caviae, Aeromonas jan-
daei and A. veronii ssp. sorbia and veronii, the clinically most
important species of Aeromonas.
Campylobacter jejuni and Campylobacter coli, the Campylobac-
ter species most commonly associated with human diarrhoeal
disease, are typically differentiated by the hippurate hydroly-
sis test. Although hippurase-positive isolates can be identiﬁed
as C. jejuni, this phenotypic test cannot differentiate between
C. jejuni ssp. jejuni and ssp. doylei or between C. coli and hip-
purase-negative strains of C. jejuni. Kolinska et al. [20], using
species-speciﬁc gene markers, reclassiﬁed into two popula-
tions 42 strains of C. jejuni previously identiﬁed by pheno-
typic tests: 26 strains of C. jejuni and 16 strains of C. coli.
MALDI-TOF MS analysis of these strains produced results in
complete agreement with the genomic tests. Fagerquist et al.
[21] also demonstrated that changes in biomarker masses,
such as that caused by an amino acid substitution, could be
used to differentiate C. jejuni ssp. jejuni and subsp. doylei, as
well as to predict phylogenetic relationships among isolates.
Helicobacter pylori, originally classiﬁed in the genus Campylo-
bacter, is an important cause of gastritis, peptic ulcers, gastric
adenocarcinoma, and gastric mucosa-associated lymphoid tis-
sue B-cell lymphomas. Phenotypic testing demonstrates a
high degree of natural variability among strains; however, Ilina
et al. [22] obtained highly reproducible mass spectra for
H. pylori isolates, permitting classiﬁcation of all strains within
the species H. pylori and differentiating them from 12 species
of Campylobacter.
Burkholderia cepacia and eight closely related species, com-
monly referred to as B. cepacia complex, are important
opportunistic pathogens responsible for infections in the
lungs, urinary tract and bloodstream in immunocompromised
patients, particularly patients with cystic ﬁbrosis or chronic
granulomatous disease. Accurate identiﬁcation of the species
within this complex and differentiation of these species from
other members of Burkholderia and related genera such as
Ralstonia, Cupriavidus and Pandoraea cannot be achieved with
phenotypic tests. Whereas some species can be identiﬁed by
sequence differences in the 16S rRNA gene, sequence analy-
sis of other housekeeping genes, such as recA, must also be
performed. Vanlaere et al. [23] analysed 75 strains of B. cepa-
cia complex isolates and related genera by MALDI-TOF MS,
and were able to classify each species correctly, with the
exception of Burkholderia anthina (genovar VII) and Burkholde-
ria pyrrocinia (genomovar IX), two species that are not com-
monly isolated in clinical specimens and that formed a
homogeneous cluster. Mellmann et al. [24] also reported that
MALDI-TOF MS could accurately identify Burkholderia species
and related non-fermentative Gram-negative rods.
Legionella pneumophila and related species are important
environmental pathogens responsible for well-documented
outbreaks of pneumonia, particularly in patients with com-
promised pulmonary function. Pennanec et al. [25] reported
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that MALDI-TOF MS could reliably differentiate Legionella
species and related organisms, and Fujinami et al. [26]
extended these studies by demonstrating that MS and PFGE
were equally reliable in identifying epidemiologically related
strains. The advantage of MALDI-TOF MS as compared with
PFGE was that the results of the analysis were available
within a few hours rather than several days. This important
study is one of the few that has directly compared MALDI-
TOF MS with PFGE.
Bacteroides fragilis and related anaerobic species are com-
monly classiﬁed and reported as Bacteroides fragilis group,
because separation by phenotypic tests is difﬁcult. Although
16S rRNA gene sequencing is accurate, the time needed for
identiﬁcation is longer and the material cost is greater [27].
In contrast, Nagy et al. [28] demonstrated that MALDI-
TOF MS identiﬁcation of Bacteroides species is accurate and
rapid, correctly identifying 98.6% of 277 clinical isolates, with
isolates being identiﬁed in less than 3 h and with minimal
expenditure on consumable reagents.
The rapid identiﬁcation and typing of potential bioterror-
ism agents have signiﬁcant public health and medical implica-
tions. Because of the nature of these microorganisms, most
laboratories are inexperienced in their identiﬁcation or are
forced to rely on multiple phenotypic, immunological and
genotypic identiﬁcation protocols. MALDI-TOF MS offers a
simple, rapid and uniform approach to the identiﬁcation of a
wide spectrum of agents. Hernychova et al. [29] demon-
strated that Coxiella burnetii could be identiﬁed rapidly at the
species level by MALDI-TOF MS, supporting the earlier ﬁnd-
ing in their laboratory that strain subtyping was feasible with
this approach. Seibold et al. [30] identiﬁed 44 strains of Fran-
cisella tularensis accurately at the subspecies level, and differ-
entiated them from six strains of Francisella philomiragia.
Lasch et al. [31] analysed 423 strains of Bacillus and related
genera, and demonstrated that MALDI-TOF MS could iden-
tify all 105 strains of Bacillus anthracis, 181 additional strains
of the Bacillus cereus group, and 137 strains of non-Bacillus
cereus bacteria. This work is particularly noteworthy because
phenotypic tests and sequence analysis of the 16S rRNA
gene cannot reliably differentiate members of the Bacillus cer-
eus group. An obvious concern in laboratories testing poten-
tial bioterrorism agents is a laboratory-acquired infection.
This concern was addressed when Larsch et al. [32] demon-
strated that Bacillus anthracis, Yersinia pestis, Burkholderia spe-
cies and related organisms were inactivated by a 30-min
pretreatment with triﬂuoroacetic acid. This treatment effec-
tively inactivated both spores and vegetative cells, and did
not compromise the MALDI-TOF MS spectral patterns.
In conclusion, MALDI-TOF MS is a powerful tool for the
classiﬁcation of a broad spectrum of bacteria, including
Gram-positive and Gram-negative cocci and rods, at the spe-
cies and subspecies level. Although some investigators care-
fully standardized the growth conditions and assay
procedures, the need for this for subtyping most organisms
of epidemiological signiﬁcance is unknown, and must be sys-
tematically studied. Additionally, comparison of MALDI-
TOF MS with genomic typing methods such as PFGE is
needed. Nevertheless, the current body of published studies
supports the thesis that MALDI-TOF MS is an important
technology for the identiﬁcation and subtyping of clinical
isolates.
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